Felipe Gómez-Caminero López

3PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 26, 2024
Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?

Luis Posado-Domínguez, María Escribano-Iglesias, Lorena Bellido-Hernández

|Apr 26, 2022
Splenosis as an incidental finding in a patient with multifactorial anemia.

Blanca Prieto García, Jesús Manuel González Santiago, Felipe Gómez-Caminero López

|Feb 25, 2021
Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors.

Alejandro Olivares-Hernández, Luis Figuero-Pérez, María A Amores Martín

Pageof 1

Frequent Collaborators

1 joint publications

Alejandro Olivares-Hernández

1 joint publications

Luis Figuero-Pérez

1 joint publications

María Del Rosario Vidal Tocino

1 joint publications

Blanca Prieto García